We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies

News   Oct 05, 2007

 
Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
 
 
Advertisement
 

RELATED ARTICLES

Therapy for Nonalcoholic Fatty Liver Disease Shows Promise in Preclinical Tests

News

Scientists have discovered a new target and a new therapy for Nonalcoholic Fatty Liver Disease (NAFLD), that has shown promising results in preclinical mouse models.

READ MORE

Light-activated Nanoparticles Inhibit Tumor Growth

News

A unique nanoparticle to deliver a localized cancer treatment inhibits tumor growth in mice, according to new research conducted at Penn State University.

READ MORE

Asthma Drug Salbutamol Inhibits Tau Filament Formation In Vitro

News

A new study suggests that the common asthma drug called salbutamol may offer potential as a treatment for Alzheimer’s disease. Extensive analytical in vitro experiments show that salbutamol is effective at reducing the accumulation of insoluble fibres of the tau protein – which is found in the brains of people with Alzheimer’s disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE